TOP2A and multidrug-resistant tuberculosis: Quinolones are secondary therapeutic agents for multidrug-resistant TB (MDR-TB) and they target two essential bacterial topoisomerases, DNA gyrase (also known as topoisomerase II) and DNA topoisomerase IV.